A Carrier Screening Panel for couples is a specialized genetic test designed for prospective parents planning a family. It determines if both partners carry gene mutations for the same inherited recessive disorders, such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. Even if both individuals are healthy, carrying the same mutation means there is a 25% risk per pregnancy of passing the condition to their child. By identifying these potential genetic risks beforehand, couples gain vital reproductive insights, enabling them to explore proactive family-planning options, consult expert genetic counselors, and make informed, empowered medical decisions with total confidence.

A Carrier Screening Panel for an individual, or solo test, is a vital genetic assessment for anyone planning a family without partner testing or prior family history. It analyzes a person's DNA to identify if they carry recessive gene mutations for severe genetic conditions, including cystic fibrosis, spinal muscular atrophy, or sickle cell anemia. Because carriers typically experience no health symptoms themselves, this test provides essential clarity regarding hidden genetic risks. Identifying single-carrier status enables individuals to proactively discuss future family planning with their partners, seek guidance from genetic counselors, and make fully informed reproductive decisions before pregnancy.

A 24-hour urine catecholamines test measures the combined levels of adrenaline (epinephrine) and noradrenaline (norepinephrine) produced by the body over a full day. These hormones, released by the adrenal glands during stress or physical activity, regulate crucial functions like heart rate and blood pressure. The test primary screens for rare adrenal neuroendocrine tumors, such as pheochromocytomas or paragangliomas, which hypersecrete catecholamines and cause severe symptoms including persistent high blood pressure, rapid heart rate, sweating, and headaches. Collecting urine over 24 hours provides a reliable baseline, accounting for normal hourly fluctuations throughout the day.

A catecholamines test measures the levels of stress hormones—adrenaline (epinephrine) and noradrenaline (norepinephrine)— circulating in your blood or urine. Produced primarily by the adrenal glands, these vital hormones help your body manage physical and emotional stress by regulating heart rate, blood pressure, and metabolism. Doctors typically order this diagnostic test to investigate persistent hypertension, headaches, sweating, or rapid heartbeats, and to screen for rare, hormone-secreting neuroendocrine tumors like pheochromocytomas. Accurate results help clinicians pinpoint underlying endocrine disorders, ensuring patients receive timely and appropriate medical interventions.

A Complete Blood Count (CBC) and Peripheral Blood Smear test provide a comprehensive evaluation of your blood's health and cellular structure. The CBC quantifies key components, including red blood cells, white blood cells, hemoglobin, and platelets, to screen for conditions like anemia, infections, and clotting disorders. Complementing this, the peripheral blood smear involves examining a thin layer of blood under a microscope to evaluate the size, shape, and appearance of these cells. Together, these complementary diagnostic tests offer critical insights, helping clinicians identify abnormal cell morphology, detect underlying blood disorders, and effectively guide targeted medical care.

A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.

A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.